搜索
Neurosense Therapeutics Ltd
NRSN添加自选
0.465USD
-0.011-2.27%
收盘 07-31 16:00（美东）报价延迟15分钟
15.15M总市值
亏损市盈率 TTM
关于 Neurosense Therapeutics Ltd 公司
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltd简介
公司代码NRSN
公司名称Neurosense Therapeutics Ltd
上市日期Dec 09, 2021
CEOBen-Noon (Alon)
员工数量15
证券类型Ordinary Share
年结日Dec 09
公司地址11 Hamenofim St.
城市HERZLIYA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编4672562
电话97297996183
网址https://www.neurosense-tx.com/
公司代码NRSN
上市日期Dec 09, 2021
CEOBen-Noon (Alon)
Neurosense Therapeutics Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
常见问题
Neurosense Therapeutics Ltd的前五大股东是谁？
Neurosense Therapeutics Ltd 的前五大股东如下：Mr. Alon Ben-Noon
有多少机构持有Neurosense Therapeutics Ltd(NRSN)的股份？
截至2026Q1，共有33家机构持有Neurosense Therapeutics Ltd的股份，合计持有的股份价值约为367.79K，占公司总股份的1.04%。与2025Q4相比，机构持股有所增加，增幅为-2009158.00。